1H-Pyrazolo[4,3-b]pyridine-7-carboxylic acid
97%
- Product Code: 191291
CAS:
1363383-15-6
| Molecular Weight: | 163.1335 g./mol | Molecular Formula: | C₇H₅N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22566130 | |
| Melting Point: | Boiling Point: | 423.0±25.0 °C(Predicted) | |
| Density: | 1.617±0.06 g/cm3(Predicted) | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for cancer treatment. Its structure supports the development of compounds targeting specific signaling pathways in tumor cells. Also employed in the design of anti-inflammatory and neuroprotective agents due to its ability to modulate enzyme activity. Commonly found in early-stage drug discovery for optimizing lead compounds with improved selectivity and metabolic stability.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 G | 10-20 days | ฿10,110.00 |
+
-
|
| 0.500 G | 10-20 days | ฿27,910.00 |
+
-
|
1H-Pyrazolo[4,3-b]pyridine-7-carboxylic acid
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for cancer treatment. Its structure supports the development of compounds targeting specific signaling pathways in tumor cells. Also employed in the design of anti-inflammatory and neuroprotective agents due to its ability to modulate enzyme activity. Commonly found in early-stage drug discovery for optimizing lead compounds with improved selectivity and metabolic stability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :